Vanda Pharmaceuticals Inc. (VNDA) is a publicly traded Healthcare sector company. As of October 14, 2026, VNDA trades at $3.98 with a market cap of $259.99M and a P/E ratio of -0.99. VNDA moved -1.63% today. Year to date, VNDA is -48.85%; over the trailing twelve months it is -19.31%. Its 52-week range spans $3.81 to $9.94. Analyst consensus is strong buy with an average price target of $13.25. Rallies surfaces VNDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks VNDA insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $3.98 |
| Market Cap | $259.99M |
| P/E Ratio | -0.99 |
| EPS | $-4.63 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.94 |
| 52-Week Low | $3.81 |
| Volume | 706.88K |
| Avg Volume | 0 |
| Revenue (TTM) | $215.72M |
| Net Income | $-274.85M |
| Gross Margin | 0.00% |
4 analysts cover VNDA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.25.